Xilinx Inc. announced that its All Programmable 7 series FPGAs and Zynq(R)-7000 All Programmable SoCs have achieved full PCI Express(R) compliance and are now listed on the PCI-SIG integrator's list. All of Xilinx's 28nm devices passed rigorous electrical, protocol and interoperability tests at the latest PCI-SIG event held on April 15, 2013. This marked PCI-SIG's first official PCI Express Gen3 compliance and interoperability testing since the introduction of the specification. By leveraging 7 series FPGA and Zynq-7000 All Programmable SoC integrated blocks for PCI Express Gen2 and Gen3, designers can meet high system bandwidth and programmable systems integration requirements needed in a variety of markets, including communications, storage and server applications. Virtex(R)-7 and Kintex(R)-7 families support Gen3 (8 Gbps) with links for up to x8 for high throughput data center applications, and Artix(R)-7 FPGA and Zynq-7000 All Programmable SoC integrated blocks support Gen2 (5 Gbps) with links up to x4 and x8 respectively, enabling accelerated design productivity for low cost applications such as industrial and automotive.

Xilinx Inc. Presents at Barclays Global Technology, Media and Telecommunications Conference, May-22-2013 12:25 PM. Venue: Crowne Plaza Times Square, 1605 Broadway (at 49th Street), New York, New York, United States. Speakers: Moshe N. Gavrielov, Chief Executive Officer, President and Director.

Xilinx Inc. reported unaudited consolidated earnings results for the fourth quarter and year ended March 30, 2013. For the quarter, net revenue was $532.168 million against $558.973 million a year ago. Operating income was $147.227 million against $147.514 million a year ago. Income before income taxes was $138.325 million against $140.388 million a year ago. Net income was $130.620 million or $0.47 per diluted share against $122.405 million or $0.44 per diluted share a year ago. Net cash provided by operating activities was $173.653 million against $208.491 million a year ago. Purchases of property, plant and equipment was $6.212 million against $8.075 million a year ago. Annual return on equity was 17% against 21% a year ago. Net income for the quarter included a tax benefit of $12 million or $0.04 per diluted share as a result of a catch-up benefit related to the restatement of the R&D -- reinstatement of the R&D tax credit. For the year, net revenue was $2,168.652 million against $2,240.736 million a year ago. Operating income was $580.732 million against $627.773 million a year ago. Income before income taxes was $547.006 million against $597.051 million a year ago. Net income was $487.536 million or $1.79 per diluted share against $530.079 million or $1.95 per diluted share a year ago. Net cash provided by operating activities was $656.537 million against $826.739 million a year ago. Purchases of property, plant and equipment was $30.265 million against $70.071 million a year ago. Fiscal year 2013 was highlighted by sales growth from the new products, which increased more than 80% from the prior year, driving PLD share gains for the year. New product sales increased 13% sequentially, with particularly strong growth from Kintex-7 and Virtex-7 FPGAs. 28-nanometer product sales exceeded $40 million in the quarter. For the quarter ending June 2013, sales are expected to be up 1% to 5% sequentially. Gross margin is expected to be approximately 66% - 67%. Operating expenses are expected to be approximately $206 million, including $2 million of amortization of acquisition-related intangibles. June quarter tax rate is expected to be approximately 13% - 14%.